/Investor DB

Merantix Capital — 2023 Investments

1 investments dated 2023 · listed companies and verified rows first · show all

Cambrium GmbHcambrium.bioNov 2023

Cambrium designs novel molecules and materials by combining AI with bioscience disciplines such as molecular biology, protein engineering, and material science.

AI & Machine LearningBiotechDeep TechNew Materials

Mitchell Duffy(Founder)inCharlie Cotton, PhD(Founder)inCharlie Cotton(Founder)Mitchell Duffy Charlie Cotton(Founder)

Co-investorsBerliner Volksbank VenturesDG Daiwa VenturesEarth Venture CapitalGradient VenturesJuniperRedstone+5 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.